List of Pfizer's Acquisitions
Here's the year on year acquisition history of Pfizer:
Year | # Acquisitions |
|---|---|
2025 | 1 |
2023 | 1 |
2022 | 3 |
2021 | 3 |
2019 | 2 |
2016 | 3 |
2015 | 2 |
2014 | 2 |
2012 | 3 |
2011 | 2 |
2010 | 3 |
2008 | 4 |
2007 | 4 |
2006 | 2 |
2005 | 3 |
2004 | 1 |
2003 | 1 |
2002 | 1 |
Recent acquisitions by Pfizer
Pfizer's most recent acquisition - Metsera is a Biopharmaceutical company focusing on medicines for obesity and metabolic diseases, founded in 2022 and located in New York City. Pfizer acquired it in September 2025 for a price of $*****.
Here is the list of all acquisitions by Pfizer sorted by the latest acquisition date:
Acquired on | Acquired Company | Acquisition Price | Facilitators | Stake Acquired | Acquisition Multiple |
|---|---|---|---|---|---|
Sep 22, 2025 | ly{r | vldl | 80 | 529 | |
Mar 13, 2023 | iwze | kgix | 90 | 580 | |
Aug 08, 2022 | lkmu | bthr | 13 | 701 | |
May 10, 2022 | dilp | bhlt | 72 | 331 | |
Apr 07, 2022 | wvsd | ytin | 70 | 197 |
View the full list of acquisitions
Sign Up for FreeNews related to Pfizer's acquisitions
Media has covered Pfizer for a total of 258 events in the last 1 year, 48 of them have been about acquisition activity.
•
Pfizer CEO Defends $7B Bolt-On M&A Strategy Amidst Peer Acquisition FrenzyBioSpace•Aug 04, 2026•Pfizer
•
AstraZeneca in Talks for Potential $400 Billion Megadeal with Bristol Myers SquibbThe Business Times•Aug 03, 2026•Bristol-Myers Squibb, AstraZeneca, National Grid, Merck and 5 others
•
Bluesight Partners with Pfizer to Integrate SmartDose™ Source-Tagged Medications into KitCheckHIT Consultant•Jul 22, 2026•Pfizer, Bluesight
•
Chai Discovery Raises $400M Series C, Valued at $3.8B, for AI-Designed AntibodiesSiliconAngle•Jul 14, 2026•Pfizer, Novartis, Chai Discovery, Lilly
•
Pfizer Leverages Chai Discovery's AI Platform to Accelerate Drug DiscoveryContract Pharma•Jun 04, 2026•Chai Discovery, Pfizer
•
Pfizer and Innovent Biologics Partner to Advance Oncology MedicineWorld Business Outlook•May 29, 2026•Innovent Bio, Pfizer, Bristol-Myers Squibb, Chai Discovery
•
•
Pfizer and Arvinas Sell Rights to Breast Cancer Drug for $35 MillionEndpoints•May 12, 2026•Arvinas, Pfizer
•
•
Pfizer CEO Albert Bourla Signals No Interest in Transformative M&A DealsEndpoints•May 05, 2026•Pfizer